Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Anders, Junker"'
Autor:
Kirstine Nørregaard Hansen, Akiko Maehara, Manijeh Noori, Jens Trøan, Christian Oliver Fallesen, Mikkel Hougaard, Julia Ellert-Gregersen, Karsten Tange Veien, Anders Junker, Henrik Steen Hansen, Jens Flensted Lassen, Lisette Okkels Jensen
Publikováno v:
Contemporary Clinical Trials Communications, Vol 38, Iss , Pp 101260- (2024)
Introduction: Percutaneous coronary intervention with implantation of a bioresorbable scaffold (BRS) provide the vessel support for a limited period allowing the vessel to restore normal vasomotion after degradation of the BRS, opposed to treatment w
Externí odkaz:
https://doaj.org/article/047f72af8ce04c1d874f75a49335393d
Autor:
Jens Trøan, Kirstine Nørregaard Hansen, Manijeh Noori, Julia Ellert-Gregersen, Anders Junker, Karsten Tange Veien, Mikkel Hougaard, Christian Oliver Fallesen, Henrik Steen Hansen, Lisette Okkels Jensen
Publikováno v:
Cardiovascular Revascularization Medicine.
Autor:
Kirstine Nørregaard Hansen, Lisette Okkels Jensen, Michael Maeng, Martin Kirk Christensen, Manijeh Noori, Johnny Kahlert, Lars Jakobsen, Anders Junker, Phillip Freeman, Julia Ellert-Gregersen, Bent Raungaard, Christian Juhl Terkelsen, Karsten Tange Veien, Evald Høj Christiansen
Publikováno v:
Hansen, K N, Jensen, L O, Maeng, M, Christensen, M K, Noori, M, Kahlert, J, Jakobsen, L, Junker, A, Freeman, P, Ellert-Gregersen, J, Raungaard, B, Terkelsen, C J, Veien, K T & Christiansen, E H 2023, ' Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated with Percutaneous Coronary Intervention : From the SORT OUT VII Trial ', Circulation: Cardiovascular Interventions, vol. 16, no. 1, E012332 . https://doi.org/10.1161/CIRCINTERVENTIONS.122.012332
Hansen, K N, Jensen, L O, Maeng, M, Christensen, M K, Noori, M, Kahlert, J, Jakobsen, L, Junker, A, Freeman, P, Ellert-Gregersen, J, Raungaard, B, Terkelsen, C J, Veien, K T & Christiansen, E H 2023, ' Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention : From the SORT OUT VII Trial ', Circulation. Cardiovascular Interventions, vol. 16, no. 1, e012332 . https://doi.org/10.1161/CIRCINTERVENTIONS.122.012332
Hansen, K N, Jensen, L O, Maeng, M, Christensen, M K, Noori, M, Kahlert, J, Jakobsen, L, Junker, A, Freeman, P, Ellert-Gregersen, J, Raungaard, B, Terkelsen, C J, Veien, K T & Christiansen, E H 2023, ' Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention : From the SORT OUT VII Trial ', Circulation. Cardiovascular Interventions, vol. 16, no. 1, e012332 . https://doi.org/10.1161/CIRCINTERVENTIONS.122.012332
Background: Biodegradable polymer drug-eluting stents were developed to improve safety and efficacy outcomes for patients undergoing percutaneous coronary intervention. However, few long-term follow-up efficacy studies are available. The study sought
Autor:
Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen
Publikováno v:
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2023, ' Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 101, no. 1, pp. 13-21 . https://doi.org/10.1002/ccd.30480
OBJECTIVES: To compare the efficacy and safety of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (O-SES) in patients with and without acute coronary syndrome (ACS) included in the SOR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a328322cab723340935d6d4ac01587
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
https://pure.au.dk/portal/da/publications/impact-of-acute-coronary-syndrome-on-clinical-outcomes-after-revascularization-with-the-dualtherapy-cd34-antibodycovered-sirolimuseluting-combo-stent-and-the-sirolimuseluting-orsiro-stent(f41888cf-79e5-49c0-9b19-4854f821239d).html
Autor:
Jesper Khedri Jensen, Per Thayssen, Lisbeth Antonsen, Mikkel Hougaard, Anders Junker, Knud Erik Pedersen, Lisette Okkels Jensen
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 6, Iss C, Pp 19-24 (2015)
Background: Cardiogenic shock is a serious complication of a ST-segment elevation myocardial infarction (STEMI). We compared short- and long-term mortality among (1) STEMI patients with and without cardiogenic shock and (2) STEMI patients with cardio
Externí odkaz:
https://doaj.org/article/3beb2d5714754a3097c8106ea98b52c5
Autor:
JOSEPHINE GRANDT, ANNE-SOFIE H. JENSEN, MIKKEL P. WERGE, ELIAS B. RASHU, ANDERS JUNKER, LISE HOBOLTH, CHRISTIAN MORTENSEN, MOGENS VYBERG, REZA SERIZAWA, SØREN MØLLER, LISE GLUUD, NICOLAI J. WEWER ALBRECHTSEN
Publikováno v:
Diabetes. 71
Metabolic dysfunction in patients with metabolic fatty liver disease (MAFLD) may increase the risk for diabetes development. The liver is essential for the postprandial control of our metabolism and hormonal response, yet most studies focus on fastin
Autor:
ANNE-SOFIE H. JENSEN, HENRIETTE YTTING, JOSEPHINE GRANDT, ANDREAS MØLLER, MIKKEL P. WERGE, ELIAS B. RASHU, LIV E. HETLAND, ANDERS JUNKER, LISE HOBOLTH, CHRISTIAN MORTENSEN, FLEMMING TOFTENG, SØREN MØLLER, MOGENS VYBERG, REZA SERIZAWA, LISE GLUUD, NICOLAI J. WEWER ALBRECHTSEN
Publikováno v:
Diabetes. 71
Gluco-regulatory disturbances such as hepatic insulin resistance, hyperinsulinemia and prediabetes are commonly present in patients with nonalcoholic fatty liver disease (NAFLD) and those individuals may over time develop full-blown type 2 diabetes.
Autor:
Niels Bligaard, Jørgen Jeppesen, Anders Galløe, Lars Kjøller-Hansen, Evald Høj Christiansen, Peter Riis Hansen, Anders Junker, Henning Kelbæk, Thomas Engstrøm
Publikováno v:
Kjøller-Hansen, L, Kelbæk, H, Christiansen, E H, Hansen, P R, Engstrøm, T, Junker, A, Bligaard, N, Jeppesen, J L & Galløe, A M 2021, ' Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation : The Importance of Stent Size ', Cardiology (Switzerland), vol. 146, no. 6, pp. 705-712 . https://doi.org/10.1159/000517614
Kjøller-Hansen, L, Kelbæk, H, Christiansen, E H, Hansen, P R, Engstrøm, T, Junker, A, Bligaard, N, Jeppesen, J L & Galløe, A M 2021, ' Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation : The Importance of Stent Size ', Cardiology, vol. 146, no. 6, pp. 705-712 . https://doi.org/10.1159/000517614
Kjøller-Hansen, L, Kelbæk, H, Christiansen, E H, Hansen, P R, Engstrøm, T, Junker, A, Bligaard, N, Jeppesen, J L & Galløe, A M 2021, ' Predictors of 10-Year Stent-Related Adverse Outcomes after Coronary Drug-Eluting Stent Implantation : The Importance of Stent Size ', Cardiology, vol. 146, no. 6, pp. 705-712 . https://doi.org/10.1159/000517614
Introduction: The predictors of stent treatment failure and their importance 10 years after treatment with drug-eluting stents (DESs) have not been reported in detail. Methods: Data were retrieved from the SORT-OUT II database encompassing 2,849 non-
Autor:
Gary S. Mintz, Mikkel Hougaard, Lisbeth Antonsen, Per Thayssen, Anders Junker, Henrik Steen Hansen, Lisette Okkels Jensen, Akiko Maehara
Publikováno v:
Hougaard, M, Hansen, H S, Thayssen, P, Maehara, A, Antonsen, L, Junker, A, Mintz, G S & Jensen, L O 2020, ' Influence of ezetimibe on plaque morphology in patients with ST Elevation Myocardial Infarction assessed by Optical Coherence Tomography : An OCTIVUS sub-study ', Cardiovascular Revascularization Medicine, vol. 21, no. 11, pp. 1417-1424 . https://doi.org/10.1016/j.carrev.2019.04.021
Aims: The aim of the trial was to examine the influence of ezetimibe on plaque morphology in patients with ST-segment Elevation Myocardial Infarction (STEMI)with respect to fibrous cap thickness (FCT)and arcs of lipid plaque, calcific plaque, and mac
Autor:
Lars Jakobsen, Evald H. Christiansen, Phillip Freeman, Johnny Kahlert, Karsten Veien, Michael Maeng, Bent Raungaard, Julia Ellert, Steen D. Kristensen, Martin K. Christensen, Christian J. Terkelsen, Troels Thim, Ashkan Eftekhari, Rebekka V. Jensen, Nicolaj B. Støttrup, Anders Junker, Henrik S. Hansen, Lisette O. Jensen
Publikováno v:
Jakobsen, L, Christiansen, E H, Freeman, P, Kahlert, J, Veien, K, Maeng, M, Raungaard, B, Ellert, J, Kristensen, S D, Christensen, M K, Terkelsen, C J, Thim, T, Eftekhari, A, Jensen, R V, Støttrup, N B, Junker, A, Hansen, H S & Jensen, L O 2022, ' Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent ', Catheterization and Cardiovascular Interventions, vol. 99, no. 7, pp. 1965-1975 . https://doi.org/10.1002/ccd.30175
OBJECTIVES: To compare the efficacy and safety of the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent (DTS) and the sirolimus-eluting Orsiro stent (SES) in patients with and without diabetes mellitus (DM) included in the Scandinavian